Add to ORKGThis invention relates to methods of treating or preventing cancers such solid tumors, as well as other disease relating to excessive or insufficient immune responses, arising from the discovery of natural ligands of NKp44 that mediate immunosuppression
Provided herein are methods and compositions inter alia for treating diseases, including hyperprolif...
is a disease that has eluded medicinal approaches for many years and as a result new and improved th...
Disclosed herein are methods for determining whether an individual with cancer is suitable for a tre...
The subject invention pertains to materials and methods for treating oncological disorders. The subj...
The accumulation of mutated somatic cells due to the incompetency of body’s immune system may lead t...
International audienceAfter many years of research, recent advances have shed new light on the role ...
WOS: 000359383700007PubMed ID: 25934338Immunotherapy is a promising field that offers alternative me...
Biological response modifiers improve the body's ability to fight cancer by immunostimulation. Altho...
The subject invention concerns materials and methods for inhibiting the Akt/PKB pathway. In one embo...
The subject invention concerns materials and methods for inhibiting the Akt/PKB pathway. In one embo...
Cancer is a mutagenic disorder which causes uncontrollable growth of cells in the body. This uncontr...
Natural killer (NK) cells are innate lymphoid cells that have a significant role in regulating the d...
NK cells are lymphocytes with antitumor properties and can directly lyse tumor cells in a non-MHC-re...
Natural killer cells (NK cells) are a family of lymphocytes with a natural ability to kill infected,...
Despite advances in the diagnostic and therapeutic modalities, the prognosis of several solid tumor ...
Provided herein are methods and compositions inter alia for treating diseases, including hyperprolif...
is a disease that has eluded medicinal approaches for many years and as a result new and improved th...
Disclosed herein are methods for determining whether an individual with cancer is suitable for a tre...
The subject invention pertains to materials and methods for treating oncological disorders. The subj...
The accumulation of mutated somatic cells due to the incompetency of body’s immune system may lead t...
International audienceAfter many years of research, recent advances have shed new light on the role ...
WOS: 000359383700007PubMed ID: 25934338Immunotherapy is a promising field that offers alternative me...
Biological response modifiers improve the body's ability to fight cancer by immunostimulation. Altho...
The subject invention concerns materials and methods for inhibiting the Akt/PKB pathway. In one embo...
The subject invention concerns materials and methods for inhibiting the Akt/PKB pathway. In one embo...
Cancer is a mutagenic disorder which causes uncontrollable growth of cells in the body. This uncontr...
Natural killer (NK) cells are innate lymphoid cells that have a significant role in regulating the d...
NK cells are lymphocytes with antitumor properties and can directly lyse tumor cells in a non-MHC-re...
Natural killer cells (NK cells) are a family of lymphocytes with a natural ability to kill infected,...
Despite advances in the diagnostic and therapeutic modalities, the prognosis of several solid tumor ...
Provided herein are methods and compositions inter alia for treating diseases, including hyperprolif...
is a disease that has eluded medicinal approaches for many years and as a result new and improved th...
Disclosed herein are methods for determining whether an individual with cancer is suitable for a tre...